<DOC>
	<DOCNO>NCT00937534</DOCNO>
	<brief_summary>The purpose study compare assess safety pharmacokinetic characteristic oral administration fimasartan ( BR-A-657∙K ) healthy elderly young male volunteer .</brief_summary>
	<brief_title>Study Compare Assess Safety Pharmacokinetic Characteristics After Oral Administration Fimasartan ( BR-A-657∙K ) Healthy Elderly Young Male Volunteers</brief_title>
	<detailed_description>Fimasartan ( BR-A-657-K ) , selective blocker AT1 receptor subtype , show rapid potent antihypertensive effect many hypertensive model . Phase I study , Fimasartan ( BR-A-657-K ) 20 mg ~ 480 mg single dose healthy subject , demonstrate Fimasartan ( BR-A-657-K ) safe well tolerate . Another phase I study , Fimasartan ( BR-A-657-K ) 120mg 360mg dose 7 day , also show Fimasartan ( BR-A-657-K ) safe tolerable though one temporal adverse event observe high dose . A open-labeled , single-dosing , parallel Clinical Study Evaluate pharmacokinetic characteristic oral administration fimasartan healthy elderly young male volunteer . 22 male healthy volunteer enrol 2 month . In part A , 240 mg fimasartan per day take young male healthy volunteer day 1 . Then blood urine sample collect 0 , 0.5 , 1 , 1.5 , 2 , 2.5 , 3 , 4 , 6 , 8 , 12 , 24 48 hour administration . In part B , 240 mg hydrochlorothiazide per day take elderly male healthy volunteer day 1 . Then blood urine sample collect 0 , 0.5 , 1 , 1.5 , 2 , 2.5 , 3 , 4 , 6 , 8 , 12 , 24 48 hour administration .</detailed_description>
	<criteria>age young : 1945 year elderly : 65 year sex : male body weight : great 55 kg patient contraindication angiotensin II receptor antagonist . patient history liver , renal , gastrointestinal , hematological cardiac diseases patient history disease might affect absorption drug patient HIV , type B C hepatitis smoker 20 cigarette per day</criteria>
	<gender>Male</gender>
	<minimum_age>19 Years</minimum_age>
	<maximum_age>N/A</maximum_age>
	<verification_date>November 2009</verification_date>
	<keyword>Fimasartan</keyword>
	<keyword>healthy elderly young male volunteer</keyword>
	<keyword>pharmacokinetic</keyword>
</DOC>